Breakdown | |||||
TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.99B | 2.95B | 1.89B | 2.30B | 1.80B | 2.10B | Gross Profit |
866.00M | 833.00M | 835.00M | 854.00M | 753.00M | 820.00M | EBIT |
654.00M | 641.00M | 463.00M | 565.00M | 507.00M | 544.00M | EBITDA |
641.00M | 716.00M | 41.00M | 648.00M | 578.00M | 612.00M | Net Income Common Stockholders |
-603.00M | -805.00M | -165.00M | 906.00M | 901.00M | 558.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
76.00M | 335.00M | 122.00M | 558.00M | 117.00M | 324.00M | Total Assets |
15.44B | 15.56B | 17.15B | 17.38B | 16.15B | 15.77B | Total Debt |
4.70B | 4.48B | 4.54B | 4.29B | 3.99B | 4.37B | Net Debt |
4.62B | 4.14B | 4.42B | 3.73B | 3.87B | 4.05B | Total Liabilities |
6.28B | 6.21B | 6.59B | 6.18B | 5.49B | 5.63B | Stockholders Equity |
9.17B | 9.35B | 10.56B | 11.13B | 10.59B | 10.09B |
Cash Flow | Free Cash Flow | ||||
810.00M | 540.00M | -62.00M | 888.00M | 630.00M | 446.00M | Operating Cash Flow |
812.00M | 542.00M | -57.00M | 896.00M | 635.00M | 450.00M | Investing Cash Flow |
-213.00M | 126.00M | -315.00M | -436.00M | -492.00M | -443.00M | Financing Cash Flow |
-750.00M | -455.00M | -64.00M | -19.00M | -350.00M | 183.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
61 Neutral | $2.83B | 10.72 | 0.40% | 6.10% | 5.80% | -21.26% | |
55 Neutral | $9.35B | ― | -6.29% | 2.50% | 22.66% | -3.80% | |
$5.93B | 297.42 | 1.03% | 1.49% | ― | ― | ||
$733.67M | 49.75 | 1.57% | 5.20% | ― | ― | ||
$44.85B | 67.53 | 5.14% | 0.86% | ― | ― | ||
$6.15B | ― | -1.94% | 4.63% | ― | ― | ||
$12.44B | 17.92 | 5.94% | 4.54% | ― | ― |
Mirvac Group announced the cessation of certain securities, specifically the lapse of 646,913 LTP performance rights and 144,645 STI performance rights, due to unmet conditions. This cessation may impact the company’s capital structure and could influence investor perceptions regarding the company’s performance and future prospects.
Mirvac Group’s operational update for the third quarter of 2025 highlights continued momentum across its business segments, with strong residential sales growth and significant progress in capital partnerships for major developments. The company maintained high occupancy rates across its investment portfolio and achieved notable leasing success, particularly in the office and industrial sectors. Mirvac’s strategic objectives for FY25 are on track, supported by a strong balance sheet and positive market conditions, positioning the company well for future earnings and growth.
Mirvac Group has announced a change in the registry address for its Sydney office of MUFG Corporate Markets (AU) Limited, effective from 14 April 2025. The move to Liberty Place, Level 41, 161 Castlereagh Street, Sydney, NSW 2000, does not affect telephone numbers or postal addresses. This change is part of the company’s ongoing efforts to streamline operations and maintain its strong market position in the real estate sector.